Anal Canal Squamous Cell Carcinoma

• CLINICAL_TRIALS trial_result · 2026-04-22
  Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer [Phase 2]

  This phase 2 trial update assesses nivolumab with or without ipilimumab in patients with refractory metastatic anal canal cancer, with resul…

• CLINICAL_TRIALS trial_result · 2023-06-29
  Clinical Trial Update: Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial [Phase 2]

  Feasibility Phase 2 trial evaluating LET-optimized IMPT as part of definitive chemoradiation for newly diagnosed anal canal squamous cell ca…

• CLINICAL_TRIALS trial_result · 2023-01-17
  Clinical Trial Update: Prebiotics and Probiotics During Definitive Treatment With Chemotherapy-radiotherapy SCC of the Anal Canal (BISQUIT) [Phase 2]

  Phase 2 clinical trial update investigating prebiotics and probiotics during definitive chemoradiotherapy for anal canal squamous cell carci…

• CLINICAL_TRIALS trial_result · 2016-05-19
  Clinical Trial Update: Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal [Phase 2]

  Phase II trial evaluating concurrent intensity-modulated radiotherapy with Capecitabine, Mitomycin, and Panitumumab in stage II-IIIB anal ca…

• CLINICAL_TRIALS trial_result · 2014-03-28
  Clinical Trial Update: A Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal. [Phase 2]

  A Phase 2 clinical trial completed in Brazil evaluated substituting capecitabine for 5-FU in chemoradiotherapy for squamous cell carcinoma o…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.